Advertisement

Topics

GBS/CIDP Foundation Company Profile

22:12 EDT 25th September 2017 | BioPortfolio

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms. It is caused by damage to the covering of the nerves called myelin.


News Articles [771 Associated News Articles listed on BioPortfolio]

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Chronic Inflammatory Demyelinating Polyneuropathy CIDP Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Chronic Inflammatory Demyelinating Polyneuropathy...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10072017] Prices from USD $5750

DelveInsight's Chronic Inflammatory Demyelinating Polyneuropathy CIDP Market Insights, Epidemiology and Market Forecast 2025 Reports provides an overview of the disease and global market size of the...

FDA Accepts sBLA for Treatment of Rare Immune-Mediated Disorder

NewsFDA accepts CSL Behring's supplemental Biologics License Application for Hizentra chronic inflammatory demyelinating polyneuropathy (CIDP) indication. CIDP is a rare immune-mediated disorder of th...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

DelveInsight's, Chronic Inflammatory Demyelinating Polyneuropathy CIDPPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Chronic...

Chronic Inflammatory Demyelinating Polyneuropathy CIDP Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 01072017] Prices from USD $2000

DelveInsight's, Chronic Inflammatory Demyelinating Polyneuropathy CIDP Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 report provides comprehensive insights about marketed and...

Kessler Foundation awarded major Wallerstein Foundation grant for stroke research

(Kessler Foundation) Kessler Foundation was awarded a $250,000 grant by the Wallerstein Foundation for Geriatric Life Improvement. The three-year grant will advance the Foundation's stroke rehabilitat...

Skoll Foundation & UN Foundation Launch ‘We the Future’

New York, NY (PRWEB) August 17, 2017 The Skoll Foundation, TED, and United Nations Foundation have partnered to catalyze conversatio...

FDA Accepts CSL Behring's Supplemental Biologics License Application For Hizentra Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Indication

  Life Sciences Jobs   ...

Drugs and Medications [451 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [248 Associated PubMed Articles listed on BioPortfolio]

CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.

Distal symmetric polyneuropathy (DSPN) is the most common neuropathy to occur in diabetes mellitus. However, patients with diabetes can also develop inflammatory neuropathies, the most common and most...

Chronic inflammatory demyelinating polyneuropathy.

As a syndrome with typical and atypical cases, chronic inflammatory demyelinating polyneuropathy (CIDP) has been a difficult disorder to diagnose and treat. The pathophysiologic basis for CIDP has not...

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

Autoantibodies to nodal/paranodal proteins have been reported in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). To determine the frequenc...

Decreased Axon Flare Reaction to Electrical Stimulation in Patients With Chronic Demyelinating Inflammatory Polyneuropathy.

In chronic inflammatory demyelinating polyradiculopathy (CIDP), the impairment of unmyelinated nerve fibers appears unexpected. The measurement of the electrically induced axon flare reflex is a clini...

Pathways for Theoretical Advances in Visualization.

There is little doubt that having a theoretic foundation will benefit the field of visualization, including its main subfields. Because there has been a substantial amount of work on taxonomies and co...

Clinical Trials [203 Associated Clinical Trials listed on BioPortfolio]

Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

This study aims analyze the transcriptome to identify predictive biomarkers of IVIG in CIDP patients. 25 patients with a diagnosis of CIDP according to European criteria, naïve of treatme...

Panzyga in CIDP Administered at Different Infusion Rates

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable form of peripheral neuropathy with suspected autoimmune cause. The current first-line treatment is IVIG (immune glob...

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

The purpose of this study is to assess the long-term safety, tolerability, and immunogenicity of the subcutaneous (SC) treatment with Immune Globulin Subcutaneous (IGSC) facilitated with r...

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is an acquired neuropathy characterized by an inflammatory multifocal segmental demyelination. Due to the clinical heteroge...

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This study is an extension study to the pivotal study IgPro20_3003 (NCT01545076). The purpose of this extension study is to investigate the long-term treatment of CIDP with IgPro20, with r...

Companies [1309 Associated Companies listed on BioPortfolio]

The GBS/CIDP Foundation International

GBS/CIDP Foundation

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in pers...

AVA Foundation

The AVA Foundation is a 501(c)(3) educational and research foundation dedicated to saving lives through promoting risk-free vascular access and evidence-based clinical practice. T...

COSHAR Foundation

The COSHAR Foundation is a 501( c )3 organization dedicated to "Impacting the Health of the World, One Community at a Time." The COSHAR Foundation's NHMN includes more than 14,000 churches and 220 co...

The NASCAR Foundation

The National Association for Stock Car Auto Racing, Inc., (NASCAR) launched The NASCAR Foundation in January 2006. The Foundation is a 501(c)(3) non-profit entity that embodies the compassion of the N...

More Information about "GBS/CIDP Foundation" on BioPortfolio

We have published hundreds of GBS/CIDP Foundation news stories on BioPortfolio along with dozens of GBS/CIDP Foundation Clinical Trials and PubMed Articles about GBS/CIDP Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GBS/CIDP Foundation Companies in our database. You can also find out about relevant GBS/CIDP Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record